
|Articles|December 1, 2004
Novel filler found safe, durable
San Diego - Results from a U.S. Food and Drug Administration pivotal trial demonstrate that the injectable wrinkle filler Artecoll, composed of polymethylmethacralate (PMMA) microspheres (20 percent) suspended in an ultra-purified collagen carrier (80 percent) is an equally safe, but longer-lasting, alternative to bovine collagen for the cosmetic correction of a variety of facial contour defects, Steven R. Cohen, M.D., tells Dermatology Times.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
AbbVie Files for Vitiligo Indication, Putting Systemic Therapy Under Regulatory Review
2
Nutrafol Expands Portfolio with First and Only Hair Loss Supplement for Male Patients 50 and Older
3
Introducing Dermatology Times NP/PA Connect
4
Narrow-Spectrum Sarecycline Approved for Moderate to Severe Acne in China
5











